From Wikipedia, the free encyclopedia
Jump to: navigation, search
Stereo skeletal formula of carveol ((1S,5R)-5-yl,-1-ol)
IUPAC name
Systematic IUPAC name
Other names
3D model (JSmol)
3DMet B04241
ECHA InfoCard 100.002.507
EC Number 202-757-4
MeSH [{{{MeSH}}} {{{MeSH}}}]
RTECS number OS8400000
Molar mass 152.24 g·mol−1
Density 0.958 g cm−3
Boiling point 226 to 227 °C (439 to 441 °F; 499 to 500 K)
Irritant Xi
R-phrases (outdated) R36/37/38
S-phrases (outdated) S26 S37/39
NFPA 704
Flammability code 1: Must be pre-heated before ignition can occur. Flash point over 93 °C (200 °F). E.g., canola oil Health code 1: Exposure would cause irritation but only minor residual injury. E.g., turpentine Reactivity code 0: Normally stable, even under fire exposure conditions, and is not reactive with water. E.g., liquid nitrogen Special hazards (white): no codeNFPA 704 four-colored diamond
Flash point 98 °C (208 °F; 371 K)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YesYN ?)
Infobox references

Carveol is a natural unsaturated, monocyclic monoterpenoid alcohol that is a constituent of spearmint essential oil in the form of cis-(−)-carveol. It is a colorless fluid soluble in oils, but insoluble in water and has an odor and flavor that resemble those of spearmint and caraway. Consequently, it is used as a fragrance in cosmetics and as a flavor additive in the food industry.

It has been found to exhibit chemoprevention of mammary carcinogenesis (prevents breast cancer).[2]

An alpha-trans-dihydroxy derivative ((1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol) possesses potent antiparkinsonian activity in animal models.[3]


  1. ^ "Carveol". Chemical Entities of Biological Interest. UK: European Bioinformatics Institute. 
  2. ^ Crowell, PL; Kennan, WS; Haag, JD; Ahmad, S; Vedejs, E; Gould, MN (1992). "Chemoprevention of mammary carcinogenesis by hydroxylated derivatives of d-limonene". Carcinogenesis. 13 (7): 1261–4. PMID 1638695. doi:10.1093/carcin/13.7.1261. 
  3. ^ Ardashov, Oleg V.; Pavlova, Alla V.; Il’Ina, Irina V.; Morozova, Ekaterina A.; Korchagina, Dina V.; Karpova, Elena V.; Volcho, Konstantin P.; Tolstikova, Tat’Yana G.; Salakhutdinov, Nariman F. (2011). "Highly Potent Activity of (1R,2R,6S)-3-Methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in Animal Models of Parkinson's Disease". Journal of Medicinal Chemistry. 54 (11): 3866–3874. PMID 21534547. doi:10.1021/jm2001579.